Actinogen Medical Limited (ATGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
At close: Dec 18, 2025
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of $119.57 million as of December 29, 2025. Its market cap has increased by 117.70% in one year.
Market Cap
119.57M
Enterprise Value
110.69M
Revenue
3.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 11.50M to 119.57M, an increase of 939.86%. That is a compound annual growth rate of 13.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 119.57M | 146.70% |
| Dec 31, 2024 | 48.47M | 40.08% |
| Dec 29, 2023 | 34.60M | -71.81% |
| Dec 30, 2022 | 122.77M | -40.54% |
| Dec 31, 2021 | 206.48M | 778.52% |
| Dec 31, 2020 | 23.50M | -16.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |